Global Renal Biomarkers Market Overview
Renal biomarkers can be lipids, proteins, genes, and metabolites, among others, that are utilized to evaluate kidney function and thus, aid in the diagnosis of kidney disorders. The growing elderly population, which is more prone to develop kidney-related diseases is a significant driver of the market. Further, the rise in the funding for biomarker research and the growing demand for non-invasive or minimally invasive diagnostic methods are likely to elevate the market value. Moreover, the increase in the adoption of renal biomarkers for routine screening and diagnostics is expected to support renal biomarkers market growth.
Key Findings
- Recent data indicates that around 35.5 million Americans are living with kidney disease. The growing burden of kidney diseases is increasing the demand for renal biomarkers that can detect kidney dysfunction at earlier stages.
- In May 2024, a study published in the New England Journal of Medicine revealed that anti-nephrin autoantibodies can act as a reliable biomarker for the identification and monitoring of nephrotic syndrome. Such research studies that advance the detection and tracking of renal illnesses are set to bolster market growth in the forecast period.
- The growth in public health policies focused on kidney disease prevention and the rising funding for biomarker research are expected to elevate the market value for renal biomarkers.
Global Renal Biomarkers Market Demand Drivers
According to the American Kidney Fund, the prevalence of kidney disease is rising at an alarming rate, with people of color more prone to developing kidney failure. It is estimated that 1 in 7 or 14% of American adults are affected by kidney disease. Moreover, it is reported that 808,00 Americans are suffering from kidney failure and over 557,000 of them are receiving dialysis. The rise in the number of cases of kidney disorders, primarily due to diabetes, hypertension, and aging populations, is a significant driver of the market.
Global Renal Biomarkers Market Segmentation Analysis
The Biomarker Type Segment is Anticipated to Witness Significant Growth in the Forecast Period
Based on the biomarker type, the market segmentation includes functional biomarkers and up-regulated proteins, among others. Functional biomarkers comprise indicators of normal biological processes or kidney function. Creatinine and cystatin C are some of the common renal biomarkers that are used to assess kidney function. The increasing prevalence of kidney diseases and the rising use of biomarkers in routine health screening, especially for early detection of kidney damage, are expected to fuel the growth of this segment.
The market report also offers insights based on technique, application, end users, and region.
Global Renal Biomarkers Market: Competitive Landscape
- In November 2022, Early is Good (EIG), an Indianapolis-based diagnostics company focused on renal disease, secured USD 4 million in a seed financing round from Social Capital, a technology investment firm, to advance the development of early and accurate biomarker-based diagnostic tests for renal system diseases including kidney cancer.
- SphingoTec, a developer of innovative biomarkers for acute medical conditions, presented real-world data on its kidney function biomarker candidate proenkephalin A 119-159 (penKid) at Kidney Week 2023 of the American Society of Nephrology (ASN), revealing that penKid outperforms conventional biomarkers in the identification of delayed graft function in a span of 24 hours after kidney transplantation.
- Other players involved in the market include Abbott Laboratories, BioPorto Diagnostics AS, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Q² Solutions Company, BioMérieux SA, Randox Laboratories Ltd, Siemens Healthineers AG, Enzo Life Sciences Inc., and Pfizer Inc.
Global Renal Biomarkers Market Analysis by Region
North America is Poised to Lead the Market Share for Renal Biomarkers
The market report offers insight into various geographical locations, including North America, Europe, Asia Pacific, Latin America along with Middle East and Africa. North America dominates the market share owing to the high prevalence of chronic kidney disease and acute kidney injury in the region. The presence of the major pharmaceutical companies and premium research institutions further boosts the market growth. Moreover, robust regulatory support, increasing focus on early diagnosis, and rising investments in biomarker research are poised to aid the market expansion in the region.
Key Offerings of the Report
- The EMR report gives an overview of the global market for renal biomarkers for the time span of (2017-2023) and (2024-2032).
- The report also offers historical (2017-2023) and forecast (2024-2032) market information for the biomarker type, technique, application, end users, and region of the global market.
- The report analyses the market dynamics, covering the key demand and price indicators in the market, along with providing an assessment of the SWOT and Porter’s Five Forces models.
About Us
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which is constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Contact Us
Expert Market Research
Website: www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
